2017
DOI: 10.4103/ijc.ijc_236_17
|View full text |Cite
|
Sign up to set email alerts
|

Quality of life outcome measures using University of Washington questionnaire version 4 in early T1/T2 anterior tongue cancers with and without radiotherapy: A cross-sectional study

Abstract: Although locoregional control and disease-free survival are the major treatment-related endpoints for cancer management, QOL outcome measures have to assess to determine the impact of a treatment modality on patients well-being and for better rehabilitation of cancer-free patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
9
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 32 publications
0
9
0
Order By: Relevance
“…); 6 = Ghai et al (2021) ( I : T1 without RT, II : T2 without RT, III : T1 and T2 with RT); 7 = Gu et al (2021) ( I : ND with submandibular gland preservation, II : conventional ND); 9 = Larson et al (2021) ( I : lateral FOM, II : anterior FOM, III : alveolar ridge with FOM); 11 = Li et al (2016) ( I : PMMF, II : RFFF); 12 = Li et al (2016) ( I : RT pre‐Tx, II : RT post‐Tx, III : RT pre‐ and post‐Tx, IV : no RT); 14 = Rogers et al (2004) ( I : nil, II : rim res., III : segment res. ); 16 = Sakthivel et al (2017) ( I : surgery, II : adjuvant therapy); 17 = Seferin et al (2022) ( I : sentinel lymph node biopsy, II : cervical ND levels I–III); 21 = Wu et al (2020) ( I : classic ALTFF, II : chimeric ALTFF); 22 = Yan et al (2017) ( I : long‐term survivors, II : non‐survivors); 24 = Yuan et al (2016) ( I : RFFF, II : ALTFF); 25 = Yue et al (2018) ( I : tongue, II : other, III : no rec., IV : rec. ); 26 = Zhang et al (2013) ( I : ≤40 years, II : ≥40 years).…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…); 6 = Ghai et al (2021) ( I : T1 without RT, II : T2 without RT, III : T1 and T2 with RT); 7 = Gu et al (2021) ( I : ND with submandibular gland preservation, II : conventional ND); 9 = Larson et al (2021) ( I : lateral FOM, II : anterior FOM, III : alveolar ridge with FOM); 11 = Li et al (2016) ( I : PMMF, II : RFFF); 12 = Li et al (2016) ( I : RT pre‐Tx, II : RT post‐Tx, III : RT pre‐ and post‐Tx, IV : no RT); 14 = Rogers et al (2004) ( I : nil, II : rim res., III : segment res. ); 16 = Sakthivel et al (2017) ( I : surgery, II : adjuvant therapy); 17 = Seferin et al (2022) ( I : sentinel lymph node biopsy, II : cervical ND levels I–III); 21 = Wu et al (2020) ( I : classic ALTFF, II : chimeric ALTFF); 22 = Yan et al (2017) ( I : long‐term survivors, II : non‐survivors); 24 = Yuan et al (2016) ( I : RFFF, II : ALTFF); 25 = Yue et al (2018) ( I : tongue, II : other, III : no rec., IV : rec. ); 26 = Zhang et al (2013) ( I : ≤40 years, II : ≥40 years).…”
Section: Resultsmentioning
confidence: 99%
“…The MINORS quality scores of non‐comparative studies ranged from 44% (Vakil et al, 2012) to 69% (Fang et al, 2013; Vora et al, 2017; Zhang et al, 2020), with an average of 60%. The MINORS quality scores of comparative studies ranged from 54% (Ochoa et al, 2021; Sakthivel et al, 2017) to 75% (Ghai et al, 2021; Gu et al, 2021; Wu et al, 2020; Yan et al, 2017; Zhang et al, 2013; Zhang et al, 2020), with an average of 67%.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations